SCHEMBL7187637

SCHEMBL7187637

Clc1ccc(-c2nc3cc(-c4ccc5nc(-c6ccc(Cl)cc6)[nH]c5c4)ccc3[nH]2)cc1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.68
MEN1 O00255 7/20 0.68
KMT2A Q03164 7/20 0.68
HPGD P15428 6/20 0.68
KDM4E B2RXH2 6/20 0.68
MAPT P10636 5/20 0.68
NPC1 O15118 5/20 0.68
SMN1; SMN2 Q16637 5/20 0.68
RAB9A P51151 4/20 0.68
HSD17B10 Q99714 4/20 0.68
TP53 P04637 3/20 0.68
NFKB1 P19838 2/20 0.68
GAA P10253 2/20 0.68
APP P05067 1/20 0.68
SNCA P37840 1/20 0.68
NFKB2 Q00653 1/20 0.68
RELA Q04206 1/20 0.68
MCL1 Q07820 1/20 0.68
CYP3A4 P08684 2/20 0.62
MAPK1 P28482 2/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9033307 0.93 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL20445410 0.88 KDM4E (0.68) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL20445296 0.88 NPC1 (0.60) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL3335014 0.86 ALDH1A1 (0.61) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL8396715 0.86 ALDH1A1 (0.81) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL16281922 0.85 NPC1 (0.66) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL9032997 0.84 ALDH1A1 (0.62) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL5595593 0.84 MEN1 (0.71) ALDH1A1MEN1KMT2AHPGDKDM4E
SCHEMBL419961 0.84 MEN1 (0.77) ALDH1A1MEN1KMT2AHPGDKDM4E
Ridinilazole SCHEMBL17867397 0.84 NPC1 (0.65) ALDH1A1MEN1KMT2AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003007955-A2 BIPHENYL APURINIC/APYRIMIDINIC SITE ENDONUCLEASE INHIBITORS TO TREAT CANCER CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2003-01-30 WO claimed